- Home
- Â /Â ViewRay
ViewRay
Stock Price
$0
2024-08-19
Market Capitalization
$4.6 M
2023-09-26
Revenue
$102.2 M
FY, 2022
ViewRay Summary
Company Summary
- Overview
- ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system. Its solution integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered.
- Type
- Public
- Status
- Active
- Founded
- 2004
- HQ
- Oakwood Village, OH, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Paul Ziegler, Executive Vice President and Chief Commercial Officer
James F. Dempsey, Founder and Chief Scientific Officer
Rob Fuchs, Chief Human Resources Officer
Operating MetricsView all
Backlog
$241.3M
6.2%
FY, 2020
Patent Applications (Foreign)
83
31.4%
FY, 2020
Products Delivered (US)
18
28.6%
FY, 2020
LocationsView all
2 locations detected
Oakwood Village, OHÂ HQ
United States
2 Thermo Fisher Way
Mountain View, CA
United States
815 E Middlefield Rd
ViewRay Financials
Summary Financials
- Revenue (Q1, 2023)
- $22.5M
- Gross profit (Q1, 2023)
- ($1.4M)
- Net income (Q1, 2023)
- ($28.9M)
- Cash (Q1, 2023)
- $81.3M
- EBIT (Q1, 2023)
- ($29.6M)
- Enterprise value
- $3.8M